Items Tagged ‘UNM CCC’

February 17th, 2016

Immune Therapy for Brain Tumors: A New Promising Avenue


  Glioblastoma is a particularly aggressive type of brain cancer. Only about one fifth of adults diagnosed with it survive two years or more after their diagnosis. A new two-drug combination, currently in early clinical trials, might help people diagnosed with glioblastoma to fight the disease. In a presentation of early clinical trial data to […]

View full entry

Tags: Brain Cancer, clinical trial, glioblastoma, immune inhibitor, indoximod, News, temozolomide, UNM CCC